Editorial: macrophage activation markers predict prognosis and decompensation in patients with cirrhosis—linking gut permeability, inflammation and cirrhosis progression

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|47|6|851-853

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.6, 2018-03, pp. : 851-853

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 5, 2018-03 ,pp. : 657-664

John Wiley & Sons Inc

Access to resources Recommend Favorite

Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 335-343

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus–related cirrhosis

By  

HEPATOLOGY, Vol. 61, Iss. 6, 2015-06 ,pp. : 1809-1820

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bacterial translocation and clinical progression of HCV‐related cirrhosis in HIV‐infected patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 2, 2018-02 ,pp. : 180-186

John Wiley & Sons Inc

Access to resources Recommend Favorite

Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 3, 2018-03 ,pp. : 718-725

John Wiley & Sons Inc

Access to resources Recommend Favorite